StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$49.35−1.24 (-2.45%)

Close on Nov 16, 2026Market cap $1.47BP/E 20.4Yield 1.22%

Conmed EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Conmed's EV/EBITDA was 21.4× on Nov 11, 2026, against 18.3× a year earlier. Over the last 5 years it ranged from 12.0× to 86.3×, with a median of 23.6×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202621.4×+3.8
2025Dec 31, 202517.5×+2.2
2024Dec 31, 202415.4×−48.2
2023Dec 29, 202363.6×+28.0
2022Dec 30, 202235.6×−18.2
2021Dec 31, 202153.8×−28.2
2020Dec 31, 202082.0×+29.6
2019Dec 31, 201952.4×+19.3
2018Dec 31, 201833.1×−19.0
2017Dec 29, 201752.1×+7.3
2016Dec 30, 201644.8×+19.1
2015Dec 31, 201525.7×−2.0
2014Dec 31, 201427.7×+3.7
2013Dec 31, 201324.0×−120.3
2012Dec 31, 2012144.3×+130.6
2011Dec 30, 201113.7×−13.2
2010Dec 31, 201026.9×–

More Conmed figures

See a number that looks wrong?